Introduction
The c-Jun protein is a transcription factor that forms a variety of dimeric complexes, collectively termed AP-1. It stimulates cell-cycle progression through the induction of genes coding for components of the cell-cycle clock machinery, and through the repression of tumorsuppressor genes such as p53 and Rb. Growth-promoting agents induce the expression of c-Jun in quiescent cells, while depletion of c-Jun results in growth arrest. The ability of c-Jun to control cell proliferation is consistent with its transforming activity. The c-jun proto-oncogene is the cellular analog of the avian sarcoma virus oncogene v-jun. Overexpression of v-Jun or c-Jun results in malignant transformation of several cell lines (for a review see Herschman, 1991; Shaulian and Karin, 2002) .
Expression of c-Jun is markedly increased upon exposure of cells to a remarkably diverse array of extracellular stimuli. Among these are peptide growth factors, proinflammatory cytokines, oxidative and other forms of cellular stress, and ultraviolet (UV) irradiation (Ryder and Nathans, 1988; Brenner et al., 1989; Devary et al., 1992; Kolbus et al., 2000; Shaulian et al., 2000) . These external stimuli cause a rapid and dramatic increase in c-jun gene transcription, mainly through activation of the mitogen-activated protein (MAPK) family of serine/threonine kinases, and in particular by Jun N-terminal kinases (JNKs) and p38, which phosphorylate the transcription factors c-Jun, ATF2, and MEF2C and thereby activate transcription of the c-jun gene (Devary et al., 1991; Gupta et al., 1995; Han and Prywes, 1995; Karin, 1995; van Dam et al., 1995; Han et al., 1997) . While transcriptional control is the main mechanism for c-Jun regulation, phosphorylation of cJun by JNK also reduces the ubiquitin-dependent degradation of c-Jun (Musti et al., 1997) and UV irradiation increases transcript stability (Blattner et al., 2000) .
Studies have shown that c-Jun expression is also regulated by cell density and by the cytoskeletal network (Reisfeld and Vardimon, 1994; Lallemand et al., 1998; Oren et al., 1999) . NIH 3T3 cells or chick retinal cells that are cultured at low cell density express a high level of c-Jun, whereas at high cell density or in intact retinal tissue the expression of c-Jun is low. Depolymerization of the cytoskeleton in the intact tissue results in a rapid and sustained increase in c-Jun protein accumulation. This increase is induced by various cytoskeletondisrupting agents, including nocodazole (Noc), vinblastine, colchicine, cytochalasin B, latrunculin A, and latrunculin B, which differ in their biochemical properties and sites of action. The molecular mechanism(s) underlying the cell density and the cytoskeleton-dependent control of c-Jun expression are not known.
The cytoskeleton is a dynamic network that undergoes restructuring during a variety of cellular events including formation of cellÀcell or cellÀextracellular matrix interactions, exposure to shear stress, infiltration and invasion, and the mitotic phase of the cell cycle. Restructuring of the cytoskeleton determines cell shape and influences gene expression. Recent studies have shown that changes in cell shape and in the underlying cytoarchitecture can determine whether an individual cell will proliferate or die: cell spreading facilitates cell proliferation, whereas cell rounding caused by restriction of cell spread can induce an apoptotic response (Chen et al., 1997) . Cytoskeletal dynamics can be sensed by the MAPK signaling pathways, in particular by JNK, which is activated both by actin and by microtubule-disrupting agents (Wang et al., 1998; Yujiri et al., 1998 Yujiri et al., , 1999 Oren et al., 1999; Shtil et al., 1999; Stone and Chambers, 2000; Subbaramaiah et al., 2000; Xiao et al., 2003) . While these pathways are mainly implicated in activation of c-jun transcription, we show here that changes in cytoskeleton integrity have a profound effect on c-Jun translation. The cytoskeletal control of c-Jun translation is mediated by the untranslated regions (UTRs) of the c-Jun transcript and is not dependent on activated MAPKs. The cytoskeletal control of c-Jun translation might facilitate the substantial accumulation of c-Jun during cellular events in which c-Jun plays a critical role.
Results
Depolymerization of the cytoskeleton enhances c-Jun protein accumulation with no corresponding increase in its mRNA Studies have shown that depolymerization of the actin or microtubule network in cells of the chick retina causes a dose-and time-dependent increase in accumulation of the c-Jun protein (Oren et al., 1999) . To determine whether the increase in c-Jun accumulation represents a general pattern of response, we examined the influence of cytoskeleton-disrupting agents on c-Jun accumulation in the mammalian cell lines HeLa, HEK 293 (HEK), NIH 3T3, and COS-7. In all cell lines, addition of Noc induced a marked increase in c-Jun accumulation (Figure 1a) . The increase was apparent within 4 h and was maintained for at least 24 h. A doseand time-dependent increase in c-Jun accumulation was also induced by various other microtubule-disrupting as well as by actin-disrupting agents, including vinblastine, cytochalasin B, latrunculin A, latrunculin B (Figure 1b-d) , cytochalasin D (Figure 2a ), and colchicine (not shown). The induced effect was reversible: removal of vinblastine after 6 h (Figure 1c ), or removal of Noc after as long as 24 h of treatment (not shown), resulted in a decrease in c-Jun protein. The increase in c-Jun accumulation could not be attributed to a general, nonspecific effect on protein expression, since metabolic labeling demonstrated that general translation was decreased (40%) in Noc-treated cells (Figure 1e ). Moreover, depolymerization of the microtubule or the actin network by Noc or latrunculin B, respectively, increased the abundance of c-Jun, but did not alter the cellular amounts of c-Fos, c-Myc, or ERK (Figure 1d ). Staining with phalloidin revealed that treatment with the different agents caused distinct changes in the actin cytoskeleton. Treatment with latrunculin B caused depolymerization of the actin network, whereas treatment with the microtubule- disrupting agents (Noc and vinblastine) promoted, as expected, massive formation of stress fibers (Figure 2) . The treated cells contained normally shaped nuclei, with no evidence of apoptotic morphology, as well as active mitochondria capable of concentrating the MitoTracker dye (Figure 2 ). In accordance with its functional role, the accumulation of c-Jun in both treated and untreated cells was largely confined to the nuclei, but was considerably higher in cells treated with cytoskeleton-disrupting agents (Figure 2 ).
To determine whether the cytoskeletal network controls c-jun transcription, we measured the amounts of the c-Jun transcript in treated and untreated cells (Figure 3a) . Epidermal growth factor (EGF), a known stimulator of c-Jun transcription, was used as a control. RNA analysis disclosed that treatment with vinblastine or cytochalasin D induced a rapid and short-term increase in c-Jun mRNA. The increase was apparent 30 min after treatment and declined within 2 h to an amount similar to that in untreated cells. The Cytoskeletal control of c-Jun translation P Polak et al protein accumulation pattern differed dramatically: a small, barely detectable increase seen 30 min after treatment (see Figure 7a ) was followed by a sustained increase that was maintained for at least 24 h. This pattern was in sharp contrast to the EGF-induced concomitant increase in c-Jun mRNA and protein ( Figure 3a) . We considered the possibility that the sustained increase in c-Jun protein was due to rapid and transient increase(s) in c-Jun mRNA at time points intermediate to those examined. However, analysis of c-Jun mRNA in Noc-treated cells at shorter time intervals revealed no significant increase other than that observed 30 min after treatment. In contrast, c-Jun protein reached a particularly high level only after 7 h, and this level was maintained for 24 h ( Figure  3d and e). Similar results were also obtained in NIH 3T3 cells. Here too, c-Jun mRNA was increased after 30 min of vinblastine treatment and was barely detectable at later time points, whereas c-Jun protein reached a particularly high level after 24 h (Figure 3b and c). These findings suggest that whereas c-Jun protein accumulation in EGF-treated cells mainly reflects an increase in gene transcription, in cells treated by cytoskeleton-disrupting agents accumulation of the c-Jun protein is controlled at a post-transcriptional level.
Depolymerization of the cytoskeleton does not alter c-Jun protein stability To examine whether depolymerization of the cytoskeleton affects the stability of the c-Jun protein, we treated HeLa cells with cytochalasin B, vinblastine, or EGF, each pulsed labeled with 35 [S]methionine/cysteine, and measured the half-life of the c-Jun protein (Figure 4a) . The results clearly show that depolymerization of the cytoskeleton had little or no effect on c-Jun stability. The half-life of c-Jun after treatment with EGF was approximately 130 min, somewhat longer than that of c-Jun in untreated cells, which is reportedly 90 min (Musti et al., 1997; Treier et al., 1994) . The half-life of c-Jun in cells treated with cytochalasin B for 2 h or with vinblastine for 2, 4, or 24 h was similar to that in untreated cells (87.877.7 min; means7s.e. of three independent experiments). These results clearly indicated that the observed increase in c-Jun accumulation was not due to protein stabilization. This notion was further supported by analysis of an exogenously expressed c-Jun protein. We transfected HeLa cells with the pSV-HAjun construct, an expression vector that contains the c-Jun coding region fused to the hemagglutinin (HA) tag, under the control of the Simian virus (SV) 40 promoter. Transfection efficiency was controlled by using the pSV-Luc construct. The cells were cultured The cytoskeleton-dependent increase in c-Jun translation is mediated by c-Jun UTRs The human c-jun is an intronless gene that contains two exceptionally long UTRs. The 5 0 and 3 0 UTRs are reportedly 974 and 1364 nucleotides long, respectively (Hattori et al., 1988) . Long UTRs are also found in rodent and avian c-jun (GenBank nucleotide database). To examine the possible involvement of c-Jun UTRs in the cytoskeleton-dependent control of c-Jun expression, we generated a series of gene constructs that contain the HA-tagged c-Jun coding region flanked by the c-Jun 5 0 UTR or 3 0 UTR or both ( Figure 5a ). To mimic the low expression level of the endogenous c-Jun transcript, we placed the various gene constructs under the control of the murine c-jun promoter. To control for transfection efficiency and for possible differences in promoter activity in Noc-treated and untreated cells, the expression vectors were transfected into HeLa cells together with the reporter construct pjLuc, which contains the luciferase (Luc) reporter gene under control of the same murine c-jun promoter. The cells were cultured for 18 h in the presence or absence of Noc, and endogenous c-Jun and exogenous HA-Jun were assayed by Western blot. The results revealed that whereas accumulation of the endogenous c-Jun in all transfected cultures was similarly increased by Noc (Figure 5b) , accumulation of the exogenous HA-Jun varied markedly and was dependent on the presence of the flanking UTRs (Figure 5c ). The amounts of the HA-Jun protein were quantified by densitometric scanning, and the Nocinduced increase was calculated (Figure 5c , bottom). In the absence of the flanking UTRs, Noc had little or no effect on HA-Jun accumulation. No significant effect was observed in cells transfected with the HA-Jun construct containing the c-Jun 3 0 UTR. However, in the presence of either the 5 0 UTR or both the 5 0 and the 3 0 UTRs, HA-Jun accumulation was increased by more than five or 11-fold, respectively. Similar results were obtained upon treatment with latrunculin B (not shown). To exclude the possibility that the observed differences in HA-Jun accumulation were due to corresponding differences in transcript stability, we quantified the amounts of HA-Jun and Luc transcripts by using real-time RTÀPCR and calculated the ratio of HA-Jun mRNA to Luc mRNA (Figure 5d ). The results showed that transcripts containing the c-Jun 3 0 UTR (HAjun3 0 and 5 0 HAjun3 0 ) responded to Noc treatment, and their amount was increased by about twofold, whereas transcripts lacking the c-Jun 3 0 UTR (HAjun and 5 0 HAjun) remained unchanged. It is possible that changes in cytoskeleton integrity are sensed by stabilizing sequences in the c-Jun 3 0 UTR and cause a small increase in transcript accumulation, detectable by the sensitive real-time RTÀPCR method but not by Northern blot analysis. However, this small increase in 0 Hajun-transfected cells, the protein increased in amount by more than fivefold while the amount of the transcript remained unchanged. This finding clearly indicated that the cytoskeletal network-controlled HA-Jun transcript translation, and that this control was mediated by the c-Jun UTRs. Since in the presence of both UTRs the basal expression of HA-Jun was significantly lower than in their absence (Figure 5c ), it is conceivable that translation of the c-Jun transcript is inhibited by its long UTRs and that this inhibition is alleviated upon disruption of the cytoskeleton.
c-Jun UTRs confer a cytoskeleton-dependent control on a heterologous gene To determine whether the c-Jun 5 0 and 3 0 UTRs are sufficient on their own to mediate the cytoskeletondependent control, we replaced the HAjun coding regions in the above-described four constructs by a heterologous gene encoding the firefly Luc (Figure 6a) , and transfected the constructs into HEK cells. Use of a foreign gene enabled us to assay RNA expression by Northern blotting (Figure 6c ), which revealed three Luc transcripts whose sizes reflected the three predominant polyadenylation sites in the c-Jun 3 0 UTR (Figure 6 , lanes 5-8; Hattori et al., 1988) . The location of these sites is denoted by arrows in Figure 6a . Two of these sites are closely located and produce a lower double band. The relative abundance of the upper and lower Cytoskeletal control of c-Jun translation P Polak et al bands was not influenced by Noc, indicating that the increase in translation could not be attributed to differential use of polyadenylation sites. The amount of the Luc transcripts was normalized relative to the endogenous GAPDH. The abundance of the Luc protein was determined by assaying Luc activity per total amount of protein. We determined the translatability of each construct by calculating the amounts of Luc protein per Luc mRNA (Figure 6d) . The results showed that in the absence of the flanking UTRs, Noc had little or no effect on Luc translatability. In the presence of the 5 0 UTR, or 3 0 UTR, or both, however, Luc translatability was increased by more than three, two, or fivefold, respectively. It should be noted that in HEK cells, unlike in HeLa cells, basal expression of the reporter construct that contained the flanking c-Jun UTRs was similar to or even higher than that of the construct that lacks them. In addition, HEK cells expressed a relatively high level of the endogenous c-Jun, and depolymerization of the cytoskeleton induced an increase of only three to fivefold in accumulation of the protein (Figure 6b ). The finding that depolymerization of the cytoskeleton increased the translatability of the Luc transcript indicates, however, that the presence of the c-Jun UTRs is sufficient to confer a cytoskeletondependent control of protein translation.
Cytoskeletal control of c-Jun translation is not mediated by the MAPK signaling pathways
Depolymerization of the cytoskeleton has been shown to activate specific MAPK pathways. We examined which of the three major MAPK pathways is activated in HeLa cells after Noc treatment. The analysis, performed by using specific antibodies that recognize phosphorylated (and therefore active) ERK, JNK, or p38, disclosed that whereas ERK and JNK became activated, the p38 pathway remained unchanged (Figure 7a) . Analysis of the total amounts of ERK and JNK suggested that their sustained activation resulted from phosphorylation of pre-existing molecules rather than from de novo protein synthesis. ERK activation was apparent within 30 min of treatment, whereas activation of JNK was detectable only after 8 h of treatment, and both remained active for at least 24 h. In agreement with the observed activation of JNK, analysis of c-Jun using anti-phospho c-Jun antibodies disclosed that the accumulated protein was phosphorylated (Figure 7a , upper panel).
To examine whether the MAPK pathways participate in mediating the cytoskeletal control of c-Jun expression, cells were pretreated with specific MAPK inhibitors and their effect on c-Jun induction by Noc was assayed (Figure 7b-d) . Inhibition of p38 by SB203580 caused a dose-dependent decline in c-Jun accumulation in untreated cells, but had no effect on the amount of c-Jun in Noc-treated cells. This finding suggests that whereas basal expression of c-Jun depends on p38 activity, this activity is not required for the cytoskeletondependent increase in c-Jun translation. PD98059, a specific inhibitor of the ERK activator MEK, caused a dose-dependent decline in ERK activity, but did not alter the amount of c-Jun in Noc-treated cells. It therefore appeared that the ERK pathway, although activated, played no part in enhancing c-Jun translation. Unlike the p38 and ERK inhibitors, the JNK-specific inhibitor SP600125 caused a dose-dependent decline in c-Jun protein accumulation in Noc-treated cells. However, it also reduced the accumulation of c-Jun in untreated cells (Figure 7d ). This finding might suggest that inhibition of JNK causes a decline in c-Jun accumulation by a mechanism that does not relate to its translational control. Since enhanced translation is dependent on the presence of the c-Jun UTRs, we examined whether the decline in c-Jun accumulation, by inhibition of JNK, is UTR-dependent. We did this by 
Discussion
The availability of c-Jun is a critical factor determining entry into or exit from the cell cycle. The cellular amount of c-Jun is regulated by several mechanisms, which function at the level of transcription, protein degradation, and mRNA stability. In line with recent studies demonstrating that translational control constitutes a major mechanism of gene regulation (Kozak, 1999) and that the primary target of Ras and Akt pathways is not transcription but translation (Rajasekhar et al., 2003) , this study shows that the abundance of c-Jun is also controlled translationally. We demonstrate that restructuring of the cytoskeleton controls translation of the c-Jun transcript, and that this control is mediated by c-Jun UTRs.
Depolymerization of the cytoskeleton was found here to have both an immediate and a later effect on c-Jun expression. The immediate effect targeted the transcription machinery of c-Jun, causing a rapid but relatively small increase in c-Jun mRNA, followed by a minor, barely detectable increase in the c-Jun protein. This effect resembles that of various extracellular stimuli, including growth factors, cytokines, or genotoxic stress, and is probably mediated mainly by MAPK pathways, which reportedly are activated as early as 1 or 2 min after treatment with cytoskeleton-disrupting agents (SchmidAlliana et al., 1998; Oren et al., 1999) . The later effect was prominent, and consisted of a sustained increase in c-Jun protein accumulation, which, depending on the drug and the cell line used, was detectable 2 h or more after treatment and was maintained for at least 24 h. The increase in c-Jun accumulation was reversible and upon removal of the drug, the cellular c-Jun declined to a level found in untreated cells. Most importantly, the increase in c-Jun was not accompanied by a corresponding increase in c-Jun mRNA accumulation or c-Jun protein stability, indicating that the increase was controlled at the level of translation.
In view of the fact that the c-Jun UTRs are particularly long, are conserved across species, and have the potential for forming stable secondary structures and (iii) depolymerization of the cytoskeleton increased expression of the endogenous c-Jun and the exogenous HA-Jun in HeLa cells by several fold more than in HEK cells. These differences might suggest that the molecular mechanism that enhances c-Jun translation is tightly blocked in HeLa cells, but is partially active in HEK cells, and that depolymerization of the cytoskeleton fully activates it in both cell types.
How does the cytoskeletal network control c-Jun translation? At the receiving end of this process are probably regulatory sequences in the c-Jun 5 0 and 3 0 UTRs, which -via interaction with specific RNAbinding proteins -either repress or activate translation. This mechanism might harness the internal ribosome entry site (IRES), which has been identified in chicken c-Jun 5 0 UTRs (Sehgal et al., 2000) . IRES can stimulate initiation of translation during the G2/M phase of the cell cycle, when cap-dependent protein synthesis is inhibited (Tarnowka and Baglioni, 1979; Bonneau and Sonenberg, 1987) . Most of the IRESs that have been identified to date are found in mRNA, whose protein products are associated with the control of cell growth and cell death, although Jun D, another member of the Jun family, is controlled translationally, but by a capdependent mechanism (Short and Pfarr, 2002) . Since the c-Jun protein is abundant throughout the cell cycle (Bakiri et al., 2000) , it is possible that restructuring of the cytoskeleton in cycling cells enhances translation of the c-Jun transcript, and that such translation is IRESdependent.
Cytoskeletal dynamics can be sensed by the MAPK signaling pathways, and in particular by JNK, which is activated in different cell types by both actin-and microtubule-disrupting agents (Wang et al., 1998; Yujiri et al., 1998 Yujiri et al., , 1999 Oren et al., 1999; Shtil et al., 1999; Stone and Chambers, 2000; Subbaramaiah et al., 2000; Xiao et al., 2003) . We show that although ERK and JNK were activated upon disruption of the microtubules in HeLa cells, these pathways did not mediate the cytoskeletal control of c-Jun translation. Inhibition of ERK had no effect on c-Jun accumulation, and inhibition of JNK reduced the accumulation of c-Jun but in a manner that was independent of its cytoskeletal control. Using chimeric HAjun constructs we demonstrated that JNK DN reduced HA-Jun accumulation by about twofold, irrespective of whether the constructs were bearing c-Jun UTRs or whether the cytoskeleton was disrupted. The JNK inhibitor caused a dosedependent decline in basal and Noc-induced accumulation of the c-Jun protein. Considering that JNK is involved in the control of c-jun transcription, it is conceivable that inhibition of JNK caused a decline in the cellular amount of the c-Jun transcript and thereby influenced the accumulation of the c-Jun protein. However, we also show that activation of JNK, in Noc-treated cells, caused an increase in c-Jun protein phosphorylation, but did not elevate the cellular amount of the c-Jun transcript. These findings raised the possibility that JNK activation is essential but not sufficient to induce c-jun gene transcription. Taken together, our results clearly indicated that the JNK pathway, while influencing c-Jun regulation via transcription, protein degradation, and mRNA stability, is not involved in mediating its translational control.
Compelling evidence points to crosscoupling between the cytoskeletal network and the Rho GTPase signaling pathways (Nobes and Hall, 1995; Tapon and Hall, 1997) . Members of the Rho GTPase family transduce extracellular signals into intracellular events that lead to remodeling of cytoskeletal structures. These GTPbinding proteins have also been implicated in the regulation of other biological responses, including the expression of c-Jun. Recent evidence indicates that RhoA initiates two distinct and independent pathways that bifurcate at the level of ROCK, one remodeling the actin cytoskeleton and the other, through activation of JNK, leading to phosphorylation of c-Jun and stimulation of c-jun gene transcription (Marinissen et al., 2004) . It is interesting to note that the cytoskeletal pathway independently regulates the serum response factor (SRF), a transcription factor that participates in the control of c-fos. Actin reorganization and the consequent reduction of the monomeric actin (G-actin) pool is 'sensed' by the SRF, which becomes activated (Sotiropoulos et al., 1999) . While the mechanism underlying the cytoskeletal control of c-Jun translation remains to be elucidated, it is tempting to suggest that the activation of two distinct pathways might ultimately converge into the coordinated control of c-Jun expression. Mutual interplay between the MAPK signaling pathway and the cytoskeletal network might cause a concomitant increase in c-Jun transcription and translation that facilitates production of c-Jun in an amount sufficient to promote normal or aberrant cell growth.
Materials and methods

Reagents and plasmids
Noc, vinblastine, colchicine, cytochalasin B, cytochalasin D, sodium orthovanadate (VOOH), and 12-O-tetradecanoylphorbol-13-acetate (TPA) were purchased from Sigma. SB 203580, SP 600125, and PD 98059 were from Calbiochem and EGF was from R&D Systems. Latrunculin A and B were kindly donated by Dr Y Kashman (Tel Aviv University).pSV-HAjun (Kallunki et al., 1996) Cell culture, transfection procedure, and Luc assay Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS). Confluent cultures were treated with drugs at the following final concentrations: Noc (30 mg/ml), vinblastine (40 mg/ml), cytochalasin B (50 mg/ml), latrunculin B (4 mg/ml), cytochalasin D (40 mg/ml), EGF (100 ng/ml), VOOH (1 mM), and TPA (100 nM). Confluent cultures of HeLa cells were transfected with 2À3 mg DNA/3 Â 10 5 cells, using jetPEIt (Polyplus transfection) according to the manufacturer's instructions. Confluent HEK cells were transfected with 1 mg DNA/2 Â 10 5 cells using the calcium phosphate method. The total amount of plasmid DNA was adjusted with empty vectors. Cells were allowed to recover for 5 h before being treated with drugs. Firefly Luc activity was assayed as described (de Wet et al., 1987) and recorded by a luminometer (LKB, Rockville, MD, USA).
Cell staining and fluorescence imaging HeLa cell, grown in six-well plates on glass coverslips, were treated for 18 h with drugs, as described above. For c-Jun staining, the cells were washed (twice) with buffer B (2 mM CaCl 2 in Tris-buffered saline (TBS)), fixed with 4% paraformaldehyde for 30 min, and washed twice with buffer B. Cells were permeabilized with 0.1% Triton X-100 (Sigma) for 10 min at room temperature and washed twice with buffer B. Nonspecific binding was blocked by incubation of the permeabilized cells for 30 min with buffer A (2 mM CaCl 2 , 2% bovine serum albumin in TBS) containing 200 mg/ml of normal goat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). The cells were then incubated for 1 h with buffer A containing 10 mg/ml of mouse anti-c-Jun antibody (J31920 Transduction Laboratories, BD Biosciences), washed three times with buffer A, and incubated for an additional 30 min with buffer A containing 2 mg/ml of Cy3-labeled goat anti-mouse antibodies (Jackson ImmunoResearch). After three washes with buffer A, the cells were counterstained with 0.1 mg/ml Hoechst dye 33258 (Sigma). To visualize the actin cytoskeleton, cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min, permeabilized with 0.2% Triton X-100 for 10 min, and then stained for 30 min in humid environment with phalloidin (Sigma, P1951) in PBS (1:1000). For mitochondrial staining, the cells were incubated with 100 nM MitoTracker Red CMXRos (Molecular Probes, Eugene, OR, USA) for 15 min at 371C and fixed as described above. Confocal imaging of c-Jun, mitochondria and cytoskeleton staining was performed using a Zeiss R510 confocal laser scanning microscope. Images of Hoechst staining were collected on a fluorescence microscope (Leica DMRBE).
Protein preparation and Western blot analysis
Cellular protein extracts were prepared by sonication of the cells in HEPES buffer (25 mM HEPES (pH 7.8), 0.5% Nonidet P-40, and a cocktail of protease inhibitors (Roche Diagnostics, Mannheim, Germany) as suggested) or in passive lysis buffer (Promega), followed by centrifugation at 20 000 g for 15 min at 41C. For experiments in which RNA preparation was also required, the cells were harvested from the same plate, and half of them were used to prepare protein extracts and the other half to prepare RNA extracts (see below). Protein amounts were determined using the Bradford reagent (Bio-Rad Laboratories). Western blot analysis was performed as described (Oren et al., 1999) . Briefly, equal amounts (20À40 mg) of protein were separated on 10% SDSÀPAGE gels, electroblotted onto nitrocellulose, and incubated with the following mouse antibodies (Abs): anti-HA-tag (MMS-101R; Covance, Berkeley, CA, USA), c-Jun (J31920; Transduction Laboratories, BD Biosciences), phospho-c-Jun or phospho-JNK (sc-822 or sc-6254, respectively; Santa Cruz Biotechnology Inc.), phospho-ERK or phospho-p38 (M 8159 or M8177, respectively; Sigma); or rabbit Abs: anti-JNK, p38, or p21 (sc-571, sc-535, or sc-756; Santa Cruz) or ERK (M5670, Sigma). The corresponding HRP-conjugated secondary Abs (ICN Pharmaceuticals Inc. or Jackson ImmunoResearch Laboratories Inc.) were used, and crossreactivity was visualized by the enhanced chemoluminescence (ECL) procedure (Pierce). Films were scanned and band intensity was determined using the ImageMaster 1D (version 3.01) software. Life Science Products Inc.) for the last 30 min of pretreatment, and chased for the indicated periods in the continuous presence of the various drugs. During the last 2 h of pretreatment, the cells were incubated in medium without methionine, and then chased in medium containing 2 mM of unlabeled methionine. Total cell extracts were prepared as described above. Immunoprecipitation was performed as described elsewhere (Oren et al., 1999) . The immunocomplexes were washed and then boiled for 5 min with gel sample buffer, separated by SDSÀPAGE (on 10% polyacrylamide gels), transferred to nitrocellulose, and analysed by autoradiography. Band intensity was determined using the PhosphorImager (Fujix Bas 1000, Fuji) and Tina software, version 2.10g (Raytest Isotopenmessgeraete, Strau¨benhardt, Germany).
Metabolic labeling and trichloroacetic acid precipitation
RNA preparation and analysis Cellular RNA was prepared with the TriPure RNA Isolation Reagent (Roche) according to the manufacturer's instructions. Poly(A) þ RNA was purified from total RNA using oligo(dT) magnetic beads (Dynal Biotech). For Northern blot analysis, RNA was denatured by heating at 601C for 10 min in 2.2 M formaldehyde/50% formamide, and fractionated by electrophoresis in 1.2% agarose gels containing 2.2 M formaldehyde. The fractionated RNA was transferred to a nitrocellulose filter and hybridized with specific DNA probes, labeled with 32 P by the random primer DNA labeling mix (Biological Industries, Kibbutz Beit Ha-Emek, Israel). The probes used for hybridization were a 1.4 kb EcoRV fragment of the firefly Luc, a 1.1 kb PstI fragment of human GAPDA, and a 1.8 kb EcoRI fragment of mouse c-jun. The levels of hybridization were determined by autoradiography. Films were scanned and band intensity was determined with ImageMaster 1D software, version 3.01. As a loading control, in some of the experiments, we stained the nitrocellulose filter for rRNA by soaking it in a solution of 0.5 M sodium acetate (pH 5.2) and 0.04% methylene blue for 5 min at room temperature and then rinsing it in water for 10 min.
Real-time RTÀPCR was used to quantify the relative amounts of HA-jun and Luc mRNA in transfected HeLa cells. RNA was digested with RNase-free DNase I (Fermentas s ) to remove residual DNA, and purified on the RNeasy mini-columns kit (Qiagen). First-strand cDNA synthesis was performed using the iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer's instructions. Optimal PCR primers for Luc and HAjun were designed in Primer Expression 2.0 computer software (Applied Biosystems, Foster City, CA, USA). One of the HAjun primers included the HA-tag sequence to avoid amplification of the endogenous c-Jun transcript. The following oligonucleotide primers were used: 5 0 -GCCATGTAACCCATACGATGTTC-3 0 and 5 0 -GCATCGTCATAGAAGTCGTTTCC-3 0 for the HA-Jun transcript and 5 0 -AACTGCCTGCGTGAGATTCTC-3 0 and 5 0 -TCGCAGTATCCGGAATGATTT-3 0 for the Luc transcript. PCR amplification was performed in a total of 20 ml reaction mixture containing 3 ml cDNA, 10 ml SYBR Green PCR Master Mix (Applied Biosystems), and 0.5 mM of each primer. An Applied Biosystems PRISM 7000 Sequence Detector was used to detect PCR products as they accumulated during the PCR reaction. The amplification protocol consisted of 2 min at 501C and 10 min at 951C, followed by 40 two-temperature cycles: 15 s at 951C and 1 min at 601C. At the end of the amplification, the dissociation curve protocol was performed to confirm a single peak near the calculated melting temperature of each amplicon. Amplification was run in duplicate together with a control consisting of identical samples not treated with iScript transcriptase, to exclude DNA carryover. Relative quantitation of HA-Jun and Luc levels was conducted using the comparative C T (the number of cycles to reach threshold) method. A standard curve for each gene-specific primer pair was generated with the cDNAs derived from the fivefold serial dilutions of total RNA from transfected cells, to validate that the dynamic ranges and amplification efficiencies of HA-Jun and Luc were approximately equal. The DC T value was determined by subtracting the average Luc C T value from the average HA-jun C T value. On the assumption that each cycle produces a twofold amplification, we calculated the ratio of relative differences in target abundance using the formula ratio ¼ 2 ÀðDCTÞ . The calculation was carried out by the integrated software (SDS v1.1) of the 7000 system.
